Cargando…
Insulin Glargine Safety in Pregnancy: A transplacental transfer study
OBJECTIVE: Insulin glargine (Lantus) is an extended-action insulin analog with greater stability and duration of action than regular human insulin. The long duration of action and decreased incidence of hypoglycemia provide potential advantages for its use in pregnancy. However, the placental pharma...
Autores principales: | Pollex, Erika K., Feig, Denice S., Lubetsky, Angelika, Yip, Paul M., Koren, Gideon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797979/ https://www.ncbi.nlm.nih.gov/pubmed/19808914 http://dx.doi.org/10.2337/dc09-1045 |
Ejemplares similares
-
Transplacental transfer of genotoxins and transplacental carcinogenesis.
por: Autrup, H
Publicado: (1993) -
Examination of Trace Metals and Their Potential Transplacental Transfer in Pregnancy
por: Jagodić, Jovana, et al.
Publicado: (2022) -
Cancer during Pregnancy: A Review of Preclinical and Clinical Transplacental Transfer of Anticancer Agents
por: Benoit, Laure, et al.
Publicado: (2021) -
Efficient transplacental IgG transfer in women infected with Zika virus during pregnancy
por: Singh, Tulika, et al.
Publicado: (2019) -
Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
por: Hadjiyianni, I., et al.
Publicado: (2016)